Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

T cell Bispecific Antibodies in Node-Positive Breast Cancer: Novel Therapeutic Avenue for MHC class I Loss Variants.

Messaoudene M, Mourikis TP, Michels J, Fu Y, Bonvalet M, Lacroix-Trikki M, Routy B, Fluckiger A, Rusakiewicz S, Roberti MP, Cotteret S, Flament C, Poirier-Colame V, Jacquelot N, Ghiringhelli F, Caignard A, Eggermont AMM, Kroemer G, Marabelle A, Arnedos M, Vicier C, Dogan S, Jaulin F, Sammut SJ, Cope W, Caldas C, Delaloge S, McGranahan N, André F, Zitvogel L.

Ann Oncol. 2019 Mar 29. pii: mdz112. doi: 10.1093/annonc/mdz112. [Epub ahead of print]

PMID:
30924846
2.

Protective effects of polyphenol-rich infusions from carob (Ceratonia siliqua) leaves and cladodes of Opuntia ficus-indica against inflammation associated with diet-induced obesity and DSS-induced colitis in Swiss mice.

Aboura I, Nani A, Belarbi M, Murtaza B, Fluckiger A, Dumont A, Benammar C, Tounsi MS, Ghiringhelli F, Rialland M, Khan NA, Hichami A.

Biomed Pharmacother. 2017 Dec;96:1022-1035. doi: 10.1016/j.biopha.2017.11.125. Epub 2017 Dec 6.

PMID:
29221725
3.

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L.

Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.

PMID:
29097494
4.

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.

Ivagnès A, Messaoudene M, Stoll G, Routy B, Fluckiger A, Yamazaki T, Iribarren K, Duong CPM, Fend L, Caignard A, Cremer I, LeCesne A, Adam J, Honoré C, Mir O, Chaigneau L, Berger A, Validire P, Christidis C, Brun-Ly VL, Smyth MJ, Mariette X, Salomon BL, Kroemer G, Rusakiewicz S, Zitvogel L.

Oncoimmunology. 2017 Oct 11;7(12):e1386826. doi: 10.1080/2162402X.2017.1386826. eCollection 2018.

5.

Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα.

Fluckiger A, Dumont A, Derangère V, Rébé C, de Rosny C, Causse S, Thomas C, Apetoh L, Hichami A, Ghiringhelli F, Rialland M.

Oncogene. 2016 Sep 1;35(35):4611-22. doi: 10.1038/onc.2015.523. Epub 2016 Feb 8.

PMID:
26853468
6.

Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity.

Kirchmeier M, Fluckiger AC, Soare C, Bozic J, Ontsouka B, Ahmed T, Diress A, Pereira L, Schödel F, Plotkin S, Dalba C, Klatzmann D, Anderson DE.

Clin Vaccine Immunol. 2014 Feb;21(2):174-80. doi: 10.1128/CVI.00662-13. Epub 2013 Dec 11.

7.

A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques.

Garrone P, Fluckiger AC, Mangeot PE, Gauthier E, Dupeyrot-Lacas P, Mancip J, Cangialosi A, Du Chéné I, LeGrand R, Mangeot I, Lavillette D, Bellier B, Cosset FL, Tangy F, Klatzmann D, Dalba C.

Sci Transl Med. 2011 Aug 3;3(94):94ra71. doi: 10.1126/scitranslmed.3002330.

8.

Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.

Lemaitre M, Leruez-Ville M, De Lamballerie XN, Salez N, Garrone P, Fluckiger AC, Klatzmann D, Carrat F.

Clin Microbiol Infect. 2011 May;17(5):732-7. doi: 10.1111/j.1469-0691.2010.03352.x. Epub 2010 Oct 29.

9.

Cell cycle features of primate embryonic stem cells.

Fluckiger AC, Marcy G, Marchand M, Négre D, Cosset FL, Mitalipov S, Wolf D, Savatier P, Dehay C.

Stem Cells. 2006 Mar;24(3):547-56. Epub 2005 Oct 20.

10.

[Embryonic stem cells and cell replacement therapies in the nervous system].

Fluckiger AC, Dehay C, Savatier P.

Med Sci (Paris). 2003 Jun-Jul;19(6-7):699-708. Review. French.

11.

In vitro reconstitution of human B-cell ontogeny: from CD34(+) multipotent progenitors to Ig-secreting cells.

Fluckiger AC, Sanz E, Garcia-Lloret M, Su T, Hao QL, Kato R, Quan S, de la Hera A, Crooks GM, Witte ON, Rawlings DJ.

Blood. 1998 Dec 15;92(12):4509-20.

12.

A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M.

Weng Z, Fluckiger AC, Nisitani S, Wahl MI, Le LQ, Hunter CA, Fernal AA, Le Beau MM, Witte ON.

Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12334-9.

13.

Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation.

Fluckiger AC, Li Z, Kato RM, Wahl MI, Ochs HD, Longnecker R, Kinet JP, Witte ON, Scharenberg AM, Rawlings DJ.

EMBO J. 1998 Apr 1;17(7):1973-85.

14.

Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Wahl MI, Fluckiger AC, Kato RM, Park H, Witte ON, Rawlings DJ.

Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11526-33.

15.

Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases.

Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP.

Science. 1996 Feb 9;271(5250):822-5.

PMID:
8629002
16.

B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro.

Malisan F, Fluckiger AC, Ho S, Guret C, Banchereau J, Martinez-Valdez H.

Blood. 1996 Jan 15;87(2):717-24.

17.

Pain assessment after intramuscular injection.

Surber C, Lüdin E, Flückiger A, Dubach UC, Ziegler WH.

Arzneimittelforschung. 1994 Dec;44(12):1389-94.

PMID:
7848364
18.

[Immunogenicity and stability of an aluminum-free liposomal hepatitis A vaccine (Epaxal Berna)].

Wegmann A, Zellmeyer M, Glück R, Finkel B, Flückiger A, Berger R, Just M.

Schweiz Med Wochenschr. 1994 Nov 12;124(45):2053-6. German.

PMID:
7973542
19.

IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.

Fluckiger AC, Brière F, Zurawski G, Bridon JM, Banchereau J.

Immunology. 1994 Nov;83(3):397-403.

20.

Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells.

Fluckiger AC, Durand I, Banchereau J.

J Exp Med. 1994 Jan 1;179(1):91-9.

21.

Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes.

Fluckiger AC, Garrone P, Durand I, Galizzi JP, Banchereau J.

J Exp Med. 1993 Nov 1;178(5):1473-81.

22.

Effects of interleukin 4 on human B-cell growth and differentiation.

Banchereau J, Bidaud C, Fluckiger AC, Galibert L, Garrone P, Malisan F, Pandrau D.

Res Immunol. 1993 Oct;144(8):601-5. Review. No abstract available.

PMID:
7508136
23.

[Mass screening in occupational health from the practitioner's viewpoint].

Flückiger A.

Soz Praventivmed. 1993;38 Suppl 2:S140-2. German.

PMID:
8279192
24.

Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.

Fluckiger AC, Rossi JF, Bussel A, Bryon P, Banchereau J, Defrance T.

Blood. 1992 Dec 15;80(12):3173-81.

25.

[Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].

Flückiger A, Schlup P.

Schweiz Med Wochenschr. 1992 Aug 15;122(33):1221-3. German.

PMID:
1326786
26.

Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells.

Defrance T, Fluckiger AC, Rossi JF, Magaud JP, Sotto JJ, Banchereau J.

Blood. 1992 Feb 15;79(4):990-6.

27.

In vitro Activation of B-CLL Cells.

Defrance T, Fluckiger AC, Rossi JF, Rousset F, Banchereau J.

Leuk Lymphoma. 1991;5 Suppl 1:13-9. doi: 10.3109/10428199109103373.

PMID:
27463474
28.

Experimental model for the investigation of kinetic and/or dynamic interactions between drugs and ethanol in humans.

Hartmann D, Flückiger A, Ziegler WH, Timm U, Zell M.

J Pharm Sci. 1988 Apr;77(4):299-303.

PMID:
3132551
29.
30.

[Effect of two years of deferoxamine therapy on iron balance, ferritin, liver and heart in patients with thalassemia major].

Flückiger A, Imbach P, Pfenninger E, Stocker F, Töndury P, Wagner HP, Weber J, Zuppinger K.

Helv Paediatr Acta. 1985 Sep;40(4):293-304. German.

PMID:
4077563
31.

Modification of gastric emptying after highly selective vagotomy: studies by barium and radio-isotopic meals.

Loup PW, Wellmann D, Fluckiger A, Lejeune M, Fasel J, Burri B, Mosimann R.

Scand J Gastroenterol Suppl. 1981;67:19-21. No abstract available.

PMID:
6941406
32.

[Modification of gastric emptying after a selective proximal vagotomy. Barium and isotope studies].

Loup P, Wellmann D, Fluckiger A, Burri B, Fasel J.

Schweiz Med Wochenschr. 1979 Apr 21;109(16):612-3. French.

PMID:
432593
33.

[2-years results of simultaneous continuous urethro-cysto-tonometry at the Bern University gynecological department].

Eduah SB, Flückiger A, Dreher E.

Gynakol Rundsch. 1977;17 Suppl 1:103-4. German. No abstract available.

PMID:
564807
34.

[Diagnostic limits in knee arthrography (a retrospective study) (author's transl)].

Flückiger A, Aazam-Zanganeh F.

Schweiz Rundsch Med Prax. 1975 Apr 22;64(16):491-5. French. No abstract available.

PMID:
1135155
35.

Repair of common bile duct defects using the gallbladder or cystic duct as a pedicled graft.

Sandblom P, Tabrizian M, Rigo M, Fluckiger A.

Surg Gynecol Obstet. 1975 Mar;140(3):425-32.

PMID:
1114435
36.

[Diagnosis of pyloro-duodenal ulcer by means of radiology and endoscopy].

Realini S, Bugnion M, Flückiger A, Hofstetter JR.

Schweiz Med Wochenschr. 1975 Jan 4;105(1):19-20. French.

PMID:
1121650
37.

[Arteriography in surgical diseases of liver and spleen].

Essinger A, Flückiger A.

Helv Chir Acta. 1974 Dec;41(5-6):579-86. French. No abstract available.

PMID:
4475670
38.

Simultaneous bilateral phlebography of the lower limbs and pelvis.

Essinger A, Flückiger A.

Radiol Clin Biol. 1974;43(3):217-23. No abstract available.

PMID:
4813294
39.

[Unusual collateral venous drainage in acquired occlusion of the superior vena cava].

Flückiger A.

Ann Radiol (Paris). 1972 Nov-Dec;15(11):915-7. French. No abstract available.

PMID:
4644195
40.

[Indications for demonstrating the superior vena cava and its major tributaries].

Otto R, Flückiger A, Candardjis G.

Fortschr Geb Rontgenstr Nuklearmed. 1972 Nov;117(5):514-21. German. No abstract available.

PMID:
4344706
41.

Indications for demonstration of the superior vena cava and its branches.

Otto R, Fluckiger A.

Int Surg. 1972 Sep;57(9):740-2. No abstract available.

PMID:
5071836
42.

[Enlarged gastric folds. Study of 5 cases].

Arnold J, Realini S, Flückiger A, Bugnion M, Hofstetter JR.

Schweiz Rundsch Med Prax. 1972 Feb 8;61(6):147-55. French. No abstract available.

PMID:
5015800
43.

[Anti-inflammatory radiotherapy and surgery of arachnoiditis spinalis].

Flückiger A.

Radiol Clin Biol. 1970;39(3):304-10. French. No abstract available.

PMID:
5475009
44.

[Spinal arachnoiditis. Value of surgical and radiotherapeutic treatment].

Flückiger A.

Praxis. 1969 May 6;58(18):586-98. German. No abstract available.

PMID:
5819316
45.

[Pneumostratigraphy of the pontocerebellar angle].

Oberson R, Fluckiger A.

Rev Otoneuroophtalmol. 1968 Nov;40(7):377-84. French. No abstract available.

PMID:
5306019
46.

[Lumbo-sacral tumors associated with spina biffida occulta].

Flückiger A.

Schweiz Arch Neurol Neurochir Psychiatr. 1967;99(2):201-26. French. No abstract available.

PMID:
5340210

Supplemental Content

Loading ...
Support Center